 |
Medication Safety Officers Society 3282 Members Strong A society of healthcare professionals dedicated to improving medication safety in healthcare organizations |
ISMP is receiving reports of confusion and errors with monoclonal antibody products used to treat COVID-19, due to unfamiliar co-packaging and labeling. Read this week’s ISMP newsletter featured article for safe practice recommendations: https://www.ismp.org/node/28457
Sign up now for the next MSOS Member Briefing webinar scheduled to be held on Thursday, November 18, 2021 from 1:00-2:00 PM ET.
Register Now: https://ecri.zoom.us/webinar/register/WN_266jVUPfTeOaOXignK2AVA
Short medication safety-related presentations for this webinar will include:
• Human Factors Engineering of Heparin Nurse Managed Protocol
Mark Wolf Jr., PharmD
PGY2 Medication-Use Safety and Policy Pharmacy Resident
University of Kentucky HealthCare
• Medication Events Related to Cancelled Labs
Magdalena Mastalerz, PharmD
PGY2 Health-Systems Pharmacy Administration & Leadership Resident
University of Kentucky HealthCare
With the approval of a COVID-19 vaccine for young children, ISMP is warning about the possibility of mix-ups between the pediatric formulation and the one intended for age 12 and over, since both will be available at many vaccination sites. For error prevention recommendations: https://www.ismp.org/node/28368
Disrespectful, bullying, and demeaning behavior is a silent epidemic in healthcare—take our survey to help ISMP measure what progress we have made! Deadline for participation is November 19, 2021: https://surveys.ismp.org/s3/ISMP-Survey-on-Disrespectful-Behavior-in-Hea...
The mission of the Medication Safety Officers Society (MSOS) is to advance and encourage excellence in safe medication use by providing communication, leadership, direction, and education among its members.